Qube pharmaceutical group
Qube is a pharmaceutical group founded in 2007 consisting of 4 companies from the pharmaceutical sector engaged in the research, development and manufacture of value-added products in the following pharmaceutical fields:
- Niche Generic Products
- OTC Products
- CE-marked Medical Devices
The QUBE group has an international presence and markets its products in 45 countries.
Innovation, be it in the use of cutting-edge technology in development or in the form of new delivery systems, is a constant in the work of the QUBE group companies and is reflected in the co-creation projects it is involved in with companies from other sectors.
The group also has a fund through which it invests in highly innovative, emerging pharmaceutical companies.
The group consists of 4 companies and a number of investee companies.
Committed to business ethics,
good governance and transparency
The QUBE group maintains high ethical standards in its relations with both Group employees and third parties. For that reason we have signed a Code of Ethics which develops the standards of conduct to be applied to our business and work, irrespective of where these are carried out, and reflects our commitment to business ethics, obliging us to behave ethically, honourably and honestly through good corporate governance and transparency.
To ensure the full and correct effectiveness of the Code of Ethics, an Internal Information System has been implemented . A tool made available to employees and third parties who collaborate with the QUBE group, in order to report any contrary or irregular conduct that occurs within the group or any of its member companies.
The suppliers, subcontractors, customers and third parties in legal relationships with the Group are bound by the principles of the code to the degree that it applies to them.
These are the principles and values that govern the behaviour and actions of the QUBE Group, its senior management, the members of its governing bodies and its employees:
- 01.Respect for current legislation
- 02.Economic solvency and transparency in management
- 04.Free competition
- 05.Respect for Human Rights
- 07.Protection of corporate assets
- 08.Conflict of interests
EMPRESAS DEL GRUPO
A company with headquarters in Pamplona (Navarra), created in 2008 and devoted to the development and commercialisation of innovative pharmaceuticals, which possesses a comprehensive management project covering every stage in the pharmaceutical value chain.
Pharmaceutical company with headquarters in Barcelona which specialises in the research and development of innovative, high-technology products for the field of oncology, with a special focus on the treatment of the widespread pain which cancer patients suffer.
4000 m2 production plant in the North of Navarra, built in 2015 and equipped with the latest technology for the development, production and packaging of medicated lozenges for third parties.
To contact us, fill out the following form
and we will get back to you.
Avda. Baja Navarra 1, 4o E
31002 Pamplona, SPAIN
"This company has received a grant from the Government of Navarra under the 2021 call for the Promotion of the Navarra Digital Company."